ClinicalTrials.Veeva

Menu

The Effect of Mask Combined With High Flow Oxygen on Preoxygenation During Induction of General Anesthesia in Obese Patients

Z

Zhengzhou University

Status

Enrolling

Conditions

Obese

Treatments

Device: apnoeic

Study type

Interventional

Funder types

Other

Identifiers

NCT06562660
HenanPPH-wanghuabing

Details and patient eligibility

About

There is a risk of airway-related incidents during anaesthesia associated with obesity. High-flow nasal oxygen is advocated for perioperative preoxygenation in obese patients to reduce airway adverse reactions. However, there have been no reports on whether smoking behaviors have an impact on obese men's Apnoeic oxygenation with high-flow nasal.This study compared the effects of smoking on the duration of safe apnoea times in obese males.

Full description

All patients were were divided into two groups based on smoking status: smokers(S groups), and never smokers(NS groups). Those in the smoking group were current smokers, while those in the nonsmoking group had never smoked. Both groups of patients were induced with intravenous anesthesia and received 5 minutes of high flow nasal oxygen (60 L min) prior to induction.After induction of anaesthesia, the patients were apnoeic until peripheral oxygen saturation decreased to 95 %.

Enrollment

60 estimated patients

Sex

Male

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  1. Participants ranged in age from 18 to 80 with BMI≥30 kg/m2.
  2. Participants are male obese patients undergoing elective non-thoracic surgery

Exclusion Criteria :

  1. patients were kept awake during the intubation due to cervical spine pathology.
  2. Patients with unstable hemodynamics.
  3. Patients with airway inflammatory diseases, including asthma, chronic obstructive pulmonary disease (COPD), lung cancer, pulmonary fibrosis and cystic fibrosis.
  4. Patients with upper respiratory infection and nasal blockage.
  5. Patients with Hypersensitivity to the drug.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

60 participants in 2 patient groups

Smoking group
Experimental group
Description:
In the Smoking group, the HFNC was performed after the patient lost spontaneous breathing until the end-tidal oxygen concentration reached 95 %. record the patient 's safe apnea time.
Treatment:
Device: apnoeic
never smoking
No Intervention group
Description:
no intervention

Trial contacts and locations

1

Loading...

Central trial contact

jiaqiang zhang; huabing wang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems